Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program

Ads

You May Also Like

Histogenics Corporation Receives Innovation Award

‒ Histogenics Recognized by the Smaller Business Association of New England (SBANE) as One ...

Colgate-Palmolive and Klox Technologies Enter Into Agreements for Oral Health

NEW YORK and LAVAL, Quebec, Feb. 08, 2016 (GLOBE NEWSWIRE) -- Colgate-Palmolive Company ("Colgate") ...

Aileron Therapeutics Announces the Appointment of Dr. Manuel Aivado as Chief Executive Officer

WATERTOWN, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader ...